CDRH Director Shuren to step down after 15 years
Michelle Tarver, deputy director for transformation, will serve as acting director of the FDA’s medical devices unit.
Jeff Shuren, who leads the Food and Drug Administration’s medical devices unit, will step down after 15 years as director.
Michelle Tarver, deputy director for transformation at the Center for Devices and Radiological Health, will become acting director of the group effective July 28, according to an email Tuesday from FDA Commissioner Robert Califf to staff, which an agency spokesperson shared with MedTech Dive.
Shuren, who is ...